Welcome to our dedicated page for Northpointe Bancshares news (Ticker: NPB), a resource for investors and traders seeking the latest updates and insights on Northpointe Bancshares stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Northpointe Bancshares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Northpointe Bancshares's position in the market.
Northpointe Bancshares has announced the pricing of its initial public offering of 10,420,000 shares of common stock at $14.50 per share. The offering includes 8,620,000 shares from Northpointe and 1,800,000 shares from selling shareholders. Trading is expected to begin on the New York Stock Exchange under symbol NPB on February 14, 2025.
The underwriters have a 30-day option to purchase up to 2,574 additional shares from Northpointe and 1,560,426 shares from selling shareholders. Northpointe expects to receive net proceeds of approximately $114.4 million after expenses, which will be used for general corporate purposes, including business growth and potential preferred stock redemption.
Keefe, Bruyette & Woods is acting as sole book-running manager, with Piper Sandler and Janney Montgomery Scott as co-managers.